EW – edwards lifesciences corporation (US:NYSE)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EW SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
2/10/2026
04:15 pm
ew
edwards lifesciences corporation
MISS
4.1%
10/30/2025
04:13 pm
ew
edwards lifesciences corporation
BEAT
-1.2%
7/24/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
5.5%
4/23/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
6.6%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
Top News Decliners
1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EW – edwards lifesciences corporation (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EW
SPY
QQQ
SPX
EW – edwards lifesciences corporation (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EW SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
4/16
07:05 am
ew
Low
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
4/15
06:51 am
ew
Low
Artisan Mid Cap Fund Q1 2026 Portfolio Activity [Seeking Alpha]
4/13
12:08 pm
ew
Low
Edwards Lifesciences (EW) was given a new $95.00 price target by Mizuho.
4/4
03:18 pm
ew
Low
Marie O'Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026
4/2
02:25 am
ew
Low
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance]
4/1
08:14 am
ew
Low
Edwards Lifesciences (EW) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $92.00 price target on the stock.
4/1
04:47 am
ew
Low
Boston Scientific: From Hypergrowth To Durable Compounding [Seeking Alpha]
3/31
07:20 am
ew
Low
Philips Wins FDA 510(k) Clearance for AI Heart Valve Repair Solution [Yahoo! Finance]
3/30
10:27 am
ew
Low
Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits [Yahoo! Finance]
2/10/2026
04:15 pm
ew
4.1%
MISS
10/30/2025
04:13 pm
ew
-1.2%
BEAT
7/24/2025
04:15 pm
ew
5.5%
BEAT
4/23/2025
04:15 pm
ew
6.6%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
4/13
01:21 pm
Maintains
Outperform
Outperform
Mizuho
Low
0.5%
4/13
01:21 pm
Maintains
Outperform
Outperform
Mizuho
Low
0.5%
4/6
01:11 pm
Maintains
Outperform
Outperform
Evercore ISI Group
Low
0.1%
4/1
08:14 am
Upgrades
Peer Perform
Outperform
Wolfe Research
Low
0.0%
4/1
08:14 am
Upgrades
Peer Perform
Outperform
Wolfe Research
Low
0.0%
4/1
06:43 am
Upgrades
PEER PERFORM
OUTPERFORM
WOLFE RESEARCH
Low
0.7%
4/1
06:43 am
Upgrades
PEER PERFORM
OUTPERFORM
WOLFE RESEARCH
Low
0.7%
2/11
12:40 pm
Maintains
Buy
Buy
Goldman Sachs
Low
1.4%
2/11
12:40 pm
Maintains
Buy
Buy
Goldman Sachs
Low
1.4%
4/9
07:34 pm
ew
Low
Form 4 Edwards Lifesciences For: Apr 09 Filed by: Ullem Scott B.
4/6
08:42 pm
ew
Low
Form 4 Edwards Lifesciences For: Apr 06 Filed by: Lippis Daniel J.
4/2
05:14 pm
ew
Low
Form 4 Edwards Lifesciences For: Apr 02 Filed by: BOBO DONALD E JR
3/26
06:04 pm
ew
Medium
Form SCHEDULE 13G/A Edwards Lifesciences Filed by: VANGUARD GROUP INC
3/26
04:08 pm
ew
Medium
Form ARS Edwards Lifesciences For: Dec 31
3/26
04:08 pm
ew
Medium
Form DEFA14A Edwards Lifesciences
3/26
04:06 pm
ew
Medium
Form DEF 14A Edwards Lifesciences For: May 07
3/26
04:06 pm
ew
Medium
Form DEFA14A Edwards Lifesciences
3/11
05:15 pm
ew
Low
Form 4 Edwards Lifesciences For: Mar 11 Filed by: Ullem Scott B.
Show more
Top News Gainers
3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
Top News Decliners
1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%